220100.KQ
FutureChem Co.,Ltd
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,480.00
−7.43%Year over year
Reported trailing growth
- Revenue
- +7.6%
- EBITDA
- —
- EBIT
- -10.0%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +14.1%
- EBITDA
- +0.6%
- EBIT
- +18.1%
- Net income
- -19.5%
- EPS
- -19.2%
- Free cash flow
- -72.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026